Web-based pulmonary telehabilitation: a systematic review.

Area of Science:

• Pulmonary rehabilitation
• Digital health
• Chronic Obstructive Pulmonary Disease (COPD) management

Background:

• Conventional pulmonary rehabilitation programs face accessibility challenges for many patients.
• Web-based pulmonary telerehabilitation (WBPTR) has emerged as a potential solution to improve access to care.
• WBPTR platforms are being explored for individuals with moderate to severe COPD.

Purpose of the Study:

• To systematically review and meta-analyze studies evaluating the effectiveness of WBPTR programs.
• To compare WBPTR outcomes against traditional care or control groups for COPD patients.
• To assess the impact of WBPTR on exercise capacity, quality of life, and dyspnea.

Main Methods:

• A meta-analysis was conducted on sixteen studies involving 3190 participants (1697 in WBPTR, 1493 in control groups).
• Outcomes assessed included daily step count, six-minute walking test, St. George's Respiratory Questionnaire, Chronic Respiratory Disease Questionnaire, and modified Medical Research Council Dyspnoea Scale.
• Statistical analysis was performed to determine the mean difference (MD) and confidence intervals (CI) for each outcome measure.

Main Results:

• WBPTR showed a statistically significant increase in daily step count (MD 446.66), but it did not reach clinical importance.
• No significant improvements were observed in the six-minute walking test, health-related quality of life (St. George's Respiratory Questionnaire, Chronic Respiratory Disease Questionnaire), or dyspnea (Chronic Respiratory Disease Questionnaire, mMRC).
• The observed changes in key metrics did not demonstrate substantial clinical benefits over traditional care.

Conclusions:

• WBPTR does not currently offer significant advantages over conventional pulmonary rehabilitation for COPD patients.
• While WBPTR can increase daily activity, it fails to meaningfully improve exercise performance, quality of life, or reduce breathlessness.
• WBPTR remains a viable complementary tool for COPD management and monitoring, but requires further innovation to enhance its clinical effectiveness.